Pancreatic cancer vaccine shows promise in early trial

A one-size-fits-all vaccine has shown promising results in keeping hard-to-treat pancreatic cancers from coming back. The five-year survival rate for this type of cancer is about 13%, and up to 80% of pancreatic cancers may come back.